New PET tracer could sharpen liver cancer diagnosis before surgery
NCT ID NCT02379377
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new imaging agent called 18F-FSPG to see if it can better detect liver cancer (hepatocellular carcinoma) and other liver tumors compared to standard PET scans. About 110 adults with liver cancer or benign liver tumors will receive the tracer before their scheduled surgery or transplant. The goal is to improve how doctors find and diagnose liver cancer, which could lead to more accurate treatment planning.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77090, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simpler chemo schedule tame colorectal cancer with fewer side effects?
- Can a new drug ST316 shrink Hard-to-Treat tumors?
- Can a Drug-Radiation combo outsmart Treatment-Resistant colorectal cancer?
- Can a cholesterol drug help immunotherapy fight colorectal cancer?
- Web tool aims to empower rare cancer patients in genomic choices
- Breath of life: new test could sniff out gut cancers before they spread